Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(2 sites)
Canada
Sunnybrook Health Sciences Centre, North York, Ontario Sunnybrook Health Sciences Centre, Toronto, Ontario